Targeting cell-state plasticity driven by FOXM1/CEBPB axis disrupts developmental heterogeneity and therapeutic resistance in hepatocellular carcinoma.
Zhang XF, Zuo XY, Zhu Y, Li JX, Xian JS, Zhang WX, Cheng W, Yuan J, Gong YF, Tang H, Yang XQ, Su YY, Zhang CY, Liu SS, Huang L, Wang H, Li MM, Xi SY, Tang YQ, Zhou L, Wah Lee TK, Ma S, Guan XY, Ma NF, Zhang Y, Liu M.
Zhang XF, et al. Among authors: liu ss.
J Hepatol. 2025 Oct 1:S0168-8278(25)02517-6. doi: 10.1016/j.jhep.2025.09.022. Online ahead of print.
J Hepatol. 2025.
PMID: 41043722